Intellectual property driven biotechnology company focusing on discovering and developing new bespoke pyscho-targeted therapeutics form mental and neurological health PsyBio Therapeutics Corp. (TSVX: PSYB) (OTCQB: PSYBF) will be taking part in a psychedelic drug video call series by Citi Group Global.
This was announced by the company’s chairman and chief executive officer, Evan Levine, who said the psychedelic video call series is scheduled to take place on February 3 at 10:00 eastern standard time (EST).
The event will be hosted by Neena Bitritto-Garg, vice president and biotech and research analyst at Citi Group Global Markets.
Anyone interested in taking part in the event, has first to register for the even and then contact their appropriate Citi representative directly.
